INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

CompletedOBSERVATIONAL
Enrollment

243

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Carcinoma, Renal CellLymphoma, Mantle-Cell
Interventions
OTHER

Temsirolimus (Non-Interventional Study)

There is not any intervention in this study.

Trial Locations (16)

8940

Hospital del Mar, Barcelona

12002

Hospital Provincial de Castellon, Castellon

15006

Complexo Hospitalario Universitario A Coruña, A Coruña

Complexo Hospitalario Universitario A Coruña. Hospital Teresa Herrera, A Coruña

15706

Hospital Clinico Universitario, Santiago de Compostela

28007

Hospital General Universitario Gregorio Marañon, Madrid

28033

MD Anderson Cancer Center, Madrid

28046

Hospital Universitario La Paz, Madrid

28050

Hospital de Madrid Norte - Sanchinarro, Madrid

31008

Hospital de Navarra, Pamplona

33006

Hospital Universitario Central de Asturias, Oviedo

33394

Hospital de Cabueñes, Cabueñes

35016

Complejo Hospitalario Materno-Infantil Insular de Las Palmas, Las Palmas de Gran Canaria

08025

Hospital de La Santa Creu I Sant Pau, Barcelona

08035

Hospital Vall D'Hebron, Barcelona

05004

Complejo AAsistencial de Avilla, Ávila

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY